Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 8/2011

01.08.2011 | Case Reports/Case Series

Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series

verfasst von: Carmelina Gurrieri, MD, Jonathon E. Kivela, MD, Katarina Bojanić, MD, Ralitza H. Gavrilova, MD, Randall P. Flick, MD, Juraj Sprung, MD, PhD, Toby N. Weingarten, MD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome (MELAS) is a rare inherited mitochondrial disorder associated with severe multiorgan pathology and stress-induced episodes of metabolic decompensation and lactic acidosis. The purpose of this case series is to review the medical records of patients with MELAS who underwent anesthetic care at the Mayo Clinic to observe their perioperative responses to anesthesia and to assess outcomes.

Principal findings

From September 1997 to October 2010, nine patients with MELAS were identified who underwent 20 general anesthetics, 12 prior to MELAS diagnosis. Debilitating neurologic symptoms involved eight patients, and three patients had substantial cardiac comorbidities. The patients tolerated commonly used anesthetics and muscle relaxants, including succinylcholine. Lactated Ringer’s solution was used frequently. One patient was noted to have elevated postoperative serum lactate, but his serum lactate was chronically elevated. Metabolic acidosis was not observed in any patient. Hyponatremia and hyperkalemia, sometimes profound, were observed in seven patients, but these abnormalities also occurred at times remote from surgery. Two patients developed renal dysfunction following cardiac surgery and abdominal surgery for severe sepsis.

Conclusion

The MELAS patients developed episodes of hyponatremia and hyperkalemia of variable severity unrelated to the timing of surgery, suggesting these patients are prone to major electrolyte disturbances. Given the propensity to develop acid-base disturbances and lactacidemia, it is prudent to review and normalize electrolyte abnormalities and to adjust the anesthetic plan accordingly. Fortunately, the limited data suggest that patients with MELAS tolerate commonly used anesthetic drugs well.
Literatur
1.
Zurück zum Zitat Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.PubMedCrossRef Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.PubMedCrossRef
2.
Zurück zum Zitat Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.PubMedCrossRef Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.PubMedCrossRef
3.
Zurück zum Zitat Cohen BH, Gold DR. Mitochondrial cytopathy in adults: what we know so far. Cleve Clin J Med 2001; 68: 625-42.PubMedCrossRef Cohen BH, Gold DR. Mitochondrial cytopathy in adults: what we know so far. Cleve Clin J Med 2001; 68: 625-42.PubMedCrossRef
4.
Zurück zum Zitat Goto Y. Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 1995; 3: S107-12.PubMedCrossRef Goto Y. Clinical features of MELAS and mitochondrial DNA mutations. Muscle Nerve 1995; 3: S107-12.PubMedCrossRef
5.
Zurück zum Zitat Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008; 1142: 133-58.PubMedCrossRef Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 2008; 1142: 133-58.PubMedCrossRef
6.
Zurück zum Zitat Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006; 66: 324-30.PubMedCrossRef Kaufmann P, Engelstad K, Wei Y, et al. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 2006; 66: 324-30.PubMedCrossRef
7.
Zurück zum Zitat Aouad MT, Gerges FJ, Baraka AS. Resistance to cisatracurium in a patient with MELAS syndrome. Pediatr Anesth 2005; 15: 1124-7. Aouad MT, Gerges FJ, Baraka AS. Resistance to cisatracurium in a patient with MELAS syndrome. Pediatr Anesth 2005; 15: 1124-7.
8.
Zurück zum Zitat Finsterer J, Stratil U, Bittner R, Sporn P. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth 1998; 45: 781-4.PubMedCrossRef Finsterer J, Stratil U, Bittner R, Sporn P. Increased sensitivity to rocuronium and atracurium in mitochondrial myopathy. Can J Anaesth 1998; 45: 781-4.PubMedCrossRef
9.
Zurück zum Zitat Wisely NA, Cook PR. General anaesthesia in a man with mitochondrial myopathy undergoing eye surgery. Eur J Anaesthesiol 2001; 18: 333-5.PubMed Wisely NA, Cook PR. General anaesthesia in a man with mitochondrial myopathy undergoing eye surgery. Eur J Anaesthesiol 2001; 18: 333-5.PubMed
10.
Zurück zum Zitat Naguib M, el Dawlatly AA, Ashour M, al-Bunyan M. Sensitivity to mivacurium in a patient with mitochondrial myopathy. Anesthesiology 1996; 84: 1506-9.PubMedCrossRef Naguib M, el Dawlatly AA, Ashour M, al-Bunyan M. Sensitivity to mivacurium in a patient with mitochondrial myopathy. Anesthesiology 1996; 84: 1506-9.PubMedCrossRef
11.
Zurück zum Zitat Maslow A, Lisbon A. Anesthetic considerations in patients with mitochondrial dysfunction. Anesth Analg 1993; 76: 884-6.PubMedCrossRef Maslow A, Lisbon A. Anesthetic considerations in patients with mitochondrial dysfunction. Anesth Analg 1993; 76: 884-6.PubMedCrossRef
12.
Zurück zum Zitat Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. Am J Med Genet 2001; 106: 94-101.PubMedCrossRef Chinnery PF, Turnbull DM. Epidemiology and treatment of mitochondrial disorders. Am J Med Genet 2001; 106: 94-101.PubMedCrossRef
13.
Zurück zum Zitat D’Ambra MN, Dedrick D, Savarese JJ. Kearns-Sayer syndrome and pancuronium—succinylcholine-induced neuromuscular blockade. Anesthesiology 1979; 51: 343-5.PubMedCrossRef D’Ambra MN, Dedrick D, Savarese JJ. Kearns-Sayer syndrome and pancuronium—succinylcholine-induced neuromuscular blockade. Anesthesiology 1979; 51: 343-5.PubMedCrossRef
14.
Zurück zum Zitat Parikh S, Saneto R, Falk MJ, et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009; 11: 414-30.PubMedCrossRef Parikh S, Saneto R, Falk MJ, et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009; 11: 414-30.PubMedCrossRef
15.
Zurück zum Zitat Sasano N, Fujita Y, So M, Sobue K, Sasano H, Katsuya H. Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy. J Anesth 2007; 21: 72-5.PubMedCrossRef Sasano N, Fujita Y, So M, Sobue K, Sasano H, Katsuya H. Anesthetic management of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) during laparotomy. J Anesth 2007; 21: 72-5.PubMedCrossRef
16.
Zurück zum Zitat DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Engel AG, Franzini-Armstrong C (Eds). Myology. 3rd ed. NY: Mc-Graw-Hill, Medical Publishing Division; 2003: 1623-62. DiMauro S, Bonilla E. Mitochondrial encephalomyopathies. In: Engel AG, Franzini-Armstrong C (Eds). Myology. 3rd ed. NY: Mc-Graw-Hill, Medical Publishing Division; 2003: 1623-62.
17.
Zurück zum Zitat Fayssoil A. Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome. Congest Heart Fail 2009; 15: 284-7.PubMedCrossRef Fayssoil A. Heart diseases in mitochondrial encephalomyopathy, lactic acidosis, and stroke syndrome. Congest Heart Fail 2009; 15: 284-7.PubMedCrossRef
18.
Zurück zum Zitat Sasano N, Tamura T, Azami T, Sasano H. Severe hyponatremia occurring after surgical stress in a patient with mitochondrial disease. J Anesth 2009; 23: 587-90.PubMedCrossRef Sasano N, Tamura T, Azami T, Sasano H. Severe hyponatremia occurring after surgical stress in a patient with mitochondrial disease. J Anesth 2009; 23: 587-90.PubMedCrossRef
19.
Zurück zum Zitat Kubota H, Tanabe Y, Takanashi J, Kohno Y. Episodic hyponatremia in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS). J Child Neurol 2005; 20: 116-20.PubMedCrossRef Kubota H, Tanabe Y, Takanashi J, Kohno Y. Episodic hyponatremia in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS). J Child Neurol 2005; 20: 116-20.PubMedCrossRef
20.
Zurück zum Zitat Southgate HJ, Penney MD. Severe recurrent renal salt wasting in a boy with a mitochondrial oxidative phosphorylation defect. Ann Clin Biochem 2000; 37(Pt 6): 805-8.PubMedCrossRef Southgate HJ, Penney MD. Severe recurrent renal salt wasting in a boy with a mitochondrial oxidative phosphorylation defect. Ann Clin Biochem 2000; 37(Pt 6): 805-8.PubMedCrossRef
21.
Zurück zum Zitat Boles RG, Roe T, Senadheera D, Mahnovski V, Wong LJ. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease. Eur J Pediatr 1998; 157: 643-7.PubMedCrossRef Boles RG, Roe T, Senadheera D, Mahnovski V, Wong LJ. Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease. Eur J Pediatr 1998; 157: 643-7.PubMedCrossRef
22.
Zurück zum Zitat Shimizu J, Inatsu A, Oshima S, et al. Hyperkalemia in familial mitochondrial cytopathy. Clin Nephrol 2008; 70: 348-53.PubMed Shimizu J, Inatsu A, Oshima S, et al. Hyperkalemia in familial mitochondrial cytopathy. Clin Nephrol 2008; 70: 348-53.PubMed
23.
Zurück zum Zitat Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330: 962-8.PubMedCrossRef Kadowaki T, Kadowaki H, Mori Y, et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 1994; 330: 962-8.PubMedCrossRef
24.
Zurück zum Zitat Lessell S, Kuwabara T, Feldman RG. Myopathy and succinylcholine sensitivity. Am J Ophthalmol 1969; 68: 789-96.PubMed Lessell S, Kuwabara T, Feldman RG. Myopathy and succinylcholine sensitivity. Am J Ophthalmol 1969; 68: 789-96.PubMed
26.
Zurück zum Zitat Pirttiaho HI, Sotaniemi EA, Pelkonen RO, Pitkanen U. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol 1982; 22: 441-5.PubMedCrossRef Pirttiaho HI, Sotaniemi EA, Pelkonen RO, Pitkanen U. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol 1982; 22: 441-5.PubMedCrossRef
27.
Zurück zum Zitat Soriano SG, Martyn JA. Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance. Clin Pharmacokinet 2004; 43: 71-81.PubMedCrossRef Soriano SG, Martyn JA. Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance. Clin Pharmacokinet 2004; 43: 71-81.PubMedCrossRef
28.
Zurück zum Zitat Kremer JM, Wilting J, Janssen LH. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 1988; 40: 1-47.PubMed Kremer JM, Wilting J, Janssen LH. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 1988; 40: 1-47.PubMed
29.
Zurück zum Zitat Wood M. Plasma binding and limitation of drug access to site of action. Anesthesiology 1991; 75: 721-3.PubMedCrossRef Wood M. Plasma binding and limitation of drug access to site of action. Anesthesiology 1991; 75: 721-3.PubMedCrossRef
30.
Zurück zum Zitat Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 1990; 71: 665-9.PubMedCrossRef Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 1990; 71: 665-9.PubMedCrossRef
31.
Zurück zum Zitat Wright PM, McCarthy G, Szenohradszky J, Sharma ML, Caldwell JE. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology 2004; 100: 626-33.PubMedCrossRef Wright PM, McCarthy G, Szenohradszky J, Sharma ML, Caldwell JE. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology 2004; 100: 626-33.PubMedCrossRef
32.
Zurück zum Zitat Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992; 76: 822-43.PubMedCrossRef Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. Effects on neuromuscular blockers. Anesthesiology 1992; 76: 822-43.PubMedCrossRef
33.
Zurück zum Zitat Gray HS, Slater RM, Pollard BJ. The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade. Anaesthesia 1989; 44: 379-81.PubMedCrossRef Gray HS, Slater RM, Pollard BJ. The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade. Anaesthesia 1989; 44: 379-81.PubMedCrossRef
34.
Zurück zum Zitat Audu P, Kim LI, Mehta MY, Kim J. Newer anti-epileptic drugs do not cause resistance to non-depolarizing neuromuscular blockade. Anesthesiology 2006; 105: A115 (abstract).CrossRef Audu P, Kim LI, Mehta MY, Kim J. Newer anti-epileptic drugs do not cause resistance to non-depolarizing neuromuscular blockade. Anesthesiology 2006; 105: A115 (abstract).CrossRef
35.
Zurück zum Zitat Hara H, Wakayama Y, Kouno Y, Yamada H, Tanaka M, Ozawa T. Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation. J Neurol Neurosurg Psychiatry 1994; 57: 1545-6.PubMedCrossRef Hara H, Wakayama Y, Kouno Y, Yamada H, Tanaka M, Ozawa T. Acute peripheral neuropathy, rhabdomyolysis, and severe lactic acidosis associated with 3243 A to G mitochondrial DNA mutation. J Neurol Neurosurg Psychiatry 1994; 57: 1545-6.PubMedCrossRef
36.
Zurück zum Zitat Kwon JH, Kim JS. Rhabdomyolysis in a patient with MELAS syndrome. Eur Neurol 2003; 50: 123-4.PubMedCrossRef Kwon JH, Kim JS. Rhabdomyolysis in a patient with MELAS syndrome. Eur Neurol 2003; 50: 123-4.PubMedCrossRef
37.
Zurück zum Zitat Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982; 61: 141-52. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore) 1982; 61: 141-52.
38.
Zurück zum Zitat Blum S, Robertson T, Klingberg S, Henderson RD, McCombe P. Atypical clinical presentations of the A3243G mutation, usually associated with MELAS. Internal Medicine Journal 2011; 41: 199-202.CrossRef Blum S, Robertson T, Klingberg S, Henderson RD, McCombe P. Atypical clinical presentations of the A3243G mutation, usually associated with MELAS. Internal Medicine Journal 2011; 41: 199-202.CrossRef
39.
Zurück zum Zitat Lofberg M, Jankala H, Paetau A, Harkonen M, Somer H. Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand 1998; 98: 268-75.PubMedCrossRef Lofberg M, Jankala H, Paetau A, Harkonen M, Somer H. Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand 1998; 98: 268-75.PubMedCrossRef
40.
Zurück zum Zitat Connolly BS, Feigenbaum AS, Robinson BH, Dipchand AI, Simon DK, Tarnopolsky MA. MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation. Biochem Biophys Res Commun 2010; 402: 443-7.PubMedCrossRef Connolly BS, Feigenbaum AS, Robinson BH, Dipchand AI, Simon DK, Tarnopolsky MA. MELAS syndrome, cardiomyopathy, rhabdomyolysis, and autism associated with the A3260G mitochondrial DNA mutation. Biochem Biophys Res Commun 2010; 402: 443-7.PubMedCrossRef
41.
Zurück zum Zitat Fricker RM, Raffelsberger T, Rauch-Shorny S, et al. Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency. Anesthesiology 2002; 97: 1635-7.PubMedCrossRef Fricker RM, Raffelsberger T, Rauch-Shorny S, et al. Positive malignant hyperthermia susceptibility in vitro test in a patient with mitochondrial myopathy and myoadenylate deaminase deficiency. Anesthesiology 2002; 97: 1635-7.PubMedCrossRef
42.
Zurück zum Zitat Ohtani J, Miike T, Ishitsu T. A case of malignant hyperthermia with mitochondrial dysfunction. Brain Dev 1985; 7: 249. Ohtani J, Miike T, Ishitsu T. A case of malignant hyperthermia with mitochondrial dysfunction. Brain Dev 1985; 7: 249.
43.
Zurück zum Zitat Flick RP, Gleich SJ, Herr MM, Wedel DJ. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder. Pediatr Anesth 2007; 17: 22-7.CrossRef Flick RP, Gleich SJ, Herr MM, Wedel DJ. The risk of malignant hyperthermia in children undergoing muscle biopsy for suspected neuromuscular disorder. Pediatr Anesth 2007; 17: 22-7.CrossRef
44.
Zurück zum Zitat Maurtua M, Torres A, Ibarra V, DeBoer G, Dolak J. Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review. Int J Obstet Anesth 2008; 17: 370-3.PubMedCrossRef Maurtua M, Torres A, Ibarra V, DeBoer G, Dolak J. Anesthetic management of an obstetric patient with MELAS syndrome: case report and literature review. Int J Obstet Anesth 2008; 17: 370-3.PubMedCrossRef
45.
Zurück zum Zitat Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, De Vivo DC. Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol 2007; 64: 1625-7.PubMedCrossRef Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, De Vivo DC. Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol 2007; 64: 1625-7.PubMedCrossRef
46.
Zurück zum Zitat Hirano M, Ricci E, Koenigsberger MR, et al. Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992; 2: 125-35.PubMedCrossRef Hirano M, Ricci E, Koenigsberger MR, et al. Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 1992; 2: 125-35.PubMedCrossRef
47.
Zurück zum Zitat Okajima Y, Tanabe Y, Takayanagi M, Aotsuka H. A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Heart 1998; 80: 292-5.PubMed Okajima Y, Tanabe Y, Takayanagi M, Aotsuka H. A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Heart 1998; 80: 292-5.PubMed
48.
Zurück zum Zitat Salsano E, Giovagnoli AR, Morandi L, et al. Mitochondrial dementia: a sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291T>C MELAS mutation. J Neurol Sci 2011; 300: 165-8.PubMedCrossRef Salsano E, Giovagnoli AR, Morandi L, et al. Mitochondrial dementia: a sporadic case of progressive cognitive and behavioral decline with hearing loss due to the rare m.3291T>C MELAS mutation. J Neurol Sci 2011; 300: 165-8.PubMedCrossRef
49.
Zurück zum Zitat Sato W, Tanaka M, Sugiyama S, et al. Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am Heart J 1994; 128: 733-41.PubMedCrossRef Sato W, Tanaka M, Sugiyama S, et al. Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am Heart J 1994; 128: 733-41.PubMedCrossRef
50.
Zurück zum Zitat Yoneda M, Tanaka M, Nishikimi M, et al. Pleiotropic molecular defects in energy-transducing complexes in mitochondrial encephalomyopathy (MELAS). J Neurol Sci 1989; 92: 143-58.PubMedCrossRef Yoneda M, Tanaka M, Nishikimi M, et al. Pleiotropic molecular defects in energy-transducing complexes in mitochondrial encephalomyopathy (MELAS). J Neurol Sci 1989; 92: 143-58.PubMedCrossRef
Metadaten
Titel
Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series
verfasst von
Carmelina Gurrieri, MD
Jonathon E. Kivela, MD
Katarina Bojanić, MD
Ralitza H. Gavrilova, MD
Randall P. Flick, MD
Juraj Sprung, MD, PhD
Toby N. Weingarten, MD
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 8/2011
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-011-9528-0

Weitere Artikel der Ausgabe 8/2011

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 8/2011 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.